<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table5" position="float"><object-id pub-id-type="doi">10.7554/eLife.28932.014</object-id><label>Table 5.</label><caption><title>Clinical characteristics of the qPCR model set.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Characteristic</th><th>qPCR model set <break/>(N&#160;=&#160;325)</th></tr></thead><tbody><tr><td valign="bottom">Age, years, median (SD)</td><td valign="bottom">58.0 (10.1)</td></tr><tr><td colspan="2" valign="bottom">Grade, n (%)</td></tr><tr><td valign="bottom">&#8195;Borderline</td><td valign="bottom">15 (4.6)</td></tr><tr><td valign="bottom">&#8195;1</td><td valign="bottom">21 (6.4)</td></tr><tr><td valign="bottom">&#8195;2</td><td valign="bottom">27 (8.3)</td></tr><tr><td valign="bottom">&#8195;3</td><td valign="bottom">100 (30.8)</td></tr><tr><td valign="bottom">&#8195;unspecified</td><td valign="bottom">10 (3.1)</td></tr><tr><td valign="bottom">&#8195;Not applicable</td><td valign="bottom">150 (46.2)</td></tr><tr><td colspan="2" valign="bottom">FIGO Stage, n (%)</td></tr><tr><td valign="bottom">&#8195;I/II</td><td valign="bottom">75 (23.1)</td></tr><tr><td valign="bottom">&#8195;III/IV</td><td valign="bottom">83 (25.5)</td></tr><tr><td valign="bottom">&#8195;Not applicable</td><td valign="bottom">167 (51.4)</td></tr><tr><td colspan="2" valign="bottom">Histology, n (%)</td></tr><tr><td valign="top">&#8195;Control</td><td valign="top">123 (37.8)</td></tr><tr><td valign="top">&#8195;Serous cystadenoma/cystadenofibroma</td><td valign="top">14 (4.3)</td></tr><tr><td valign="top">&#8195;Endometrioma</td><td valign="top">15 (4.6)</td></tr><tr><td valign="top">&#8195;Borderline serous tumor</td><td valign="top">15 (4.6)</td></tr><tr><td valign="top">&#8195;Serous adenocarcinoma</td><td valign="bottom">100 (30.8)</td></tr><tr><td valign="top">&#8195;Endometrioid/clear cell adenocarcinoma</td><td valign="bottom">48 (14.8)</td></tr><tr><td valign="top">&#8195;Mucinous adenocarcinoma</td><td valign="bottom">10 (3.8)</td></tr></tbody></table></table-wrap>